help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tran, N. L.
Right arrow Articles by Berens, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tran, N. L.
Right arrow Articles by Berens, M. E.
(American Journal of Pathology. 2003;162:1313-1321.)
© 2003 American Society for Investigative Pathology

The Human Fn14 Receptor Gene Is Up-Regulated in Migrating Glioma Cells in Vitro and Overexpressed in Advanced Glial Tumors

Nhan L. Tran*{dagger}, Wendy S. McDonough*{dagger}, Patrick J. Donohue{ddagger}, Jeffrey A. Winkles{ddagger}, Theresa J. Berens*, Kristen R. Ross*, Dominique B. Hoelzinger*{dagger}, Christian Beaudry*{dagger}, Stephen W. Coons§ and Michael E. Berens*{dagger}

From Neuro-Oncology Research* and the Department of Neuro-Pathology,§ Barrow Neurological Institute, Phoenix, Arizona; the Translational Genomics Research Institute,{dagger} Phoenix, Arizona; and the Vascular Biology Department,{ddagger} Jerome H. Holland Laboratory for the Biomedical Sciences, American Red Cross, Rockville, Maryland

Glioblastoma multiforme comprises the majority of human brain tumors. Patients with glioblastoma multiforme have poor survival rates, with an average life expectancy of <1 year. To assess possible mechanisms and to potentially target invasive glioma cells, we previously measured the gene expression profiles of glioma cells under migration-activated or passive states. One of the genes identified was Fn14, which encodes a cell surface receptor for the tumor necrosis factor superfamily member named TWEAK. In this study, we show that Fn14 gene expression is induced in migration-activated glioma cells in vitro and significantly increases according to tumor grade in vivo (P < 0.01), with highest levels in glioblastoma tissue specimens. The in situ expression pattern of Fn14 mRNA and protein was confined to primary glioma cells and the vascular endothelium, with no detection in adjacent normal brain. Conversely, TWEAK mRNA levels are low in glioblastoma samples relative to normal brain tissue. In addition, activation of the Fn14 receptor by addition of recombinant TWEAK resulted in increased glioma cell migration in vitro. These results suggest a positive role for TWEAK and Fn14 in glioma progression and indicate that Fn14 gene expression may serve as a marker for invasive glioma cells.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
P. A. Culp, D. Choi, Y. Zhang, J. Yin, P. Seto, S. E. Ybarra, M. Su, M. Sho, R. Steinle, M. H.L. Wong, et al.
Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms
Clin. Cancer Res., January 15, 2010; 16(2): 497 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
S. P. Fortin, M. J. Ennis, B. A. Savitch, D. Carpentieri, W. S. McDonough, J. A. Winkles, J. C. Loftus, C. Kingsley, G. Hostetter, and N. L. Tran
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Stimulation of Glioma Cell Survival Is Dependent on Akt2 Function
Mol. Cancer Res., November 1, 2009; 7(11): 1871 - 1881.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Kumar, D. Y. Makonchuk, H. Li, A. Mittal, and A. Kumar
TNF-Like Weak Inducer of Apoptosis (TWEAK) Activates Proinflammatory Signaling Pathways and Gene Expression through the Activation of TGF-{beta}-Activated Kinase 1
J. Immunol., February 15, 2009; 182(4): 2439 - 2448.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
A. L. Willis, N. L. Tran, J. M. Chatigny, N. Charlton, H. Vu, S. A.N. Brown, M. A. Black, W. S. McDonough, S. P. Fortin, J. R. Niska, et al.
The Fibroblast Growth Factor-Inducible 14 Receptor Is Highly Expressed in HER2-Positive Breast Tumors and Regulates Breast Cancer Cell Invasive Capacity
Mol. Cancer Res., May 1, 2008; 6(5): 725 - 734.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Shirahata, K. Iwao-Koizumi, S. Saito, N. Ueno, M. Oda, N. Hashimoto, J. A. Takahashi, and K. Kato
Gene Expression-Based Molecular Diagnostic System for Malignant Gliomas Is Superior to Histological Diagnosis
Clin. Cancer Res., December 15, 2007; 13(24): 7341 - 7356.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. L. Tran, W. S. McDonough, B. A. Savitch, S. P. Fortin, J. A. Winkles, M. Symons, M. Nakada, H. E. Cunliffe, G. Hostetter, D. B. Hoelzinger, et al.
Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-{kappa}B and Correlate with Poor Patient Outcome
Cancer Res., October 1, 2006; 66(19): 9535 - 9542.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. De, J.-I. Park, K. Kawamura, R. Chen, C. Klein, R. Rauch, S. M. Mulders, M. D. Sollewijn Gelpke, and A. J. W. Hsueh
Intraovarian Tumor Necrosis Factor-Related Weak Inducer of Apoptosis/Fibroblast Growth Factor-Inducible-14 Ligand-Receptor System Limits Ovarian Preovulatory Follicles from Excessive Luteinization
Mol. Endocrinol., October 1, 2006; 20(10): 2528 - 2538.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
R. E. Brown and A. Law
Morphoproteomic Demonstration of Constitutive Nuclear Factor-kappaB Activation in Glioblastoma Multiforme with Genomic Correlates and Therapeutic Implications
Ann. Clin. Lab. Sci., January 1, 2006; 36(4): 421 - 426.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Polavarapu, M. C. Gongora, J. A. Winkles, and M. Yepes
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Increases the Permeability of the Neurovascular Unit through Nuclear Factor-{kappa}B Pathway Activation
J. Neurosci., November 2, 2005; 25(44): 10094 - 10100.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Nakada, J. A. Niska, N. L. Tran, W. S. McDonough, and M. E. Berens
EphB2/R-Ras Signaling Regulates Glioma Cell Adhesion, Growth, and Invasion
Am. J. Pathol., August 1, 2005; 167(2): 565 - 576.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. L. Tran, W. S. McDonough, B. A. Savitch, T. F. Sawyer, J. A. Winkles, and M. E. Berens
The Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK)-Fibroblast Growth Factor-inducible 14 (Fn14) Signaling System Regulates Glioma Cell Survival via NF{kappa}B Pathway Activation and BCL-XL/BCL-W Expression
J. Biol. Chem., February 4, 2005; 280(5): 3483 - 3492.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Yepes, S. A.N. Brown, E. G. Moore, E. P. Smith, D. A. Lawrence, and J. A. Winkles
A Soluble Fn14-Fc Decoy Receptor Reduces Infarct Volume in a Murine Model of Cerebral Ischemia
Am. J. Pathol., February 1, 2005; 166(2): 511 - 520.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. H. Ho, H. Vu, S. A. N. Brown, P. J. Donohue, H. N. Hanscom, and J. A. Winkles
Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Overexpression in HEK293 Cells Promotes Tumor Growth and Angiogenesis in Athymic Nude Mice
Cancer Res., December 15, 2004; 64(24): 8968 - 8972.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Nakada, J. A. Niska, H. Miyamori, W. S. McDonough, J. Wu, H. Sato, and M. E. Berens
The Phosphorylation of EphB2 Receptor Regulates Migration and Invasion of Human Glioma Cells
Cancer Res., May 1, 2004; 64(9): 3179 - 3185.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Saitoh, M. Nakayama, H. Nakano, H. Yagita, N. Yamamoto, and S. Yamaoka
TWEAK Induces NF-{kappa}B2 p100 Processing and Long Lasting NF-{kappa}B Activation
J. Biol. Chem., September 19, 2003; 278(38): 36005 - 36012.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.